RU2005102549A - METHOD FOR CORRECTION OF ERYTHROPOESIS DISORDERS IN EXPERIMENTAL HYPOXIA - Google Patents

METHOD FOR CORRECTION OF ERYTHROPOESIS DISORDERS IN EXPERIMENTAL HYPOXIA Download PDF

Info

Publication number
RU2005102549A
RU2005102549A RU2005102549/14A RU2005102549A RU2005102549A RU 2005102549 A RU2005102549 A RU 2005102549A RU 2005102549/14 A RU2005102549/14 A RU 2005102549/14A RU 2005102549 A RU2005102549 A RU 2005102549A RU 2005102549 A RU2005102549 A RU 2005102549A
Authority
RU
Russia
Prior art keywords
erythropoesis
disorders
correction
hypoxia
experimental hypoxia
Prior art date
Application number
RU2005102549/14A
Other languages
Russian (ru)
Other versions
RU2285300C1 (en
Inventor
Евгений Данилович Гольдберг (RU)
Евгений Данилович Гольдберг
Александр Михайлович Дыгай (RU)
Александр Михайлович Дыгай
Глеб Николаевич Зюзьков (RU)
Глеб Николаевич Зюзьков
Original Assignee
ГУ Научно-исследовательский институт фармакологииТомского научного центра Сибирского отделени Российской академии медицинских наук НИИ фармакологииТНЦ СО РАН (RU)
ГУ Научно-исследовательский институт фармакологии Томского научного центра Сибирского отделения Российской академии медицинских наук НИИ фармакологии ТНЦ СО РАН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ГУ Научно-исследовательский институт фармакологииТомского научного центра Сибирского отделени Российской академии медицинских наук НИИ фармакологииТНЦ СО РАН (RU), ГУ Научно-исследовательский институт фармакологии Томского научного центра Сибирского отделения Российской академии медицинских наук НИИ фармакологии ТНЦ СО РАН filed Critical ГУ Научно-исследовательский институт фармакологииТомского научного центра Сибирского отделени Российской академии медицинских наук НИИ фармакологииТНЦ СО РАН (RU)
Priority to RU2005102549/14A priority Critical patent/RU2285300C1/en
Publication of RU2005102549A publication Critical patent/RU2005102549A/en
Application granted granted Critical
Publication of RU2285300C1 publication Critical patent/RU2285300C1/en

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (1)

Способ коррекции нарушений эритропоэза при экспериментальной гипоксии, заключающийся в введении препарата, отличающийся тем, что в качестве препарата используют пропранолол, который вводят однократно подкожно в дозе 5 мг/кг на 2-е сутки после моделирования гипоксии.A method for correcting erythropoiesis disorders during experimental hypoxia, which consists in administering a drug, characterized in that propranolol is used as a drug, which is administered once subcutaneously at a dose of 5 mg / kg on the 2nd day after modeling of hypoxia.
RU2005102549/14A 2005-02-02 2005-02-02 Method for correcting affected erythropoiesis at experimental hypoxia RU2285300C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2005102549/14A RU2285300C1 (en) 2005-02-02 2005-02-02 Method for correcting affected erythropoiesis at experimental hypoxia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2005102549/14A RU2285300C1 (en) 2005-02-02 2005-02-02 Method for correcting affected erythropoiesis at experimental hypoxia

Publications (2)

Publication Number Publication Date
RU2005102549A true RU2005102549A (en) 2006-07-10
RU2285300C1 RU2285300C1 (en) 2006-10-10

Family

ID=36830499

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005102549/14A RU2285300C1 (en) 2005-02-02 2005-02-02 Method for correcting affected erythropoiesis at experimental hypoxia

Country Status (1)

Country Link
RU (1) RU2285300C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2528976C1 (en) * 2013-07-11 2014-09-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации Method for simulating acquired toxic haemolytic anaemia experimentally

Also Published As

Publication number Publication date
RU2285300C1 (en) 2006-10-10

Similar Documents

Publication Publication Date Title
IL259851A (en) Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
IL193951A (en) Bridged compound with central pyrrolidine units, an intermediate compound for the preparation of the bridged compound, a process for producing the bridged compound, use of the bridged compound for the manufacture of a medicament, a pharmaceutical composition, a method of preparing a pharmaceutical composition and a method for the preparation of a pharmaceutically acceptable salt of a non-salt compound
JP2007504174A5 (en)
JP2012193216A5 (en)
JP2009506117A5 (en)
MX2010013766A (en) Rasagiline for parkinson's disease modification.
AR047993A1 (en) PHARMACEUTICAL COMPOSITION THAT PIMOBENDAN INCLUDES
TN2012000216A1 (en) Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
WO2007038506A3 (en) Method for the treatment of cachexia
WO2006050002A3 (en) Compositions for controlled delivery of pharmaceutically active compounds
EP2548552A3 (en) Titration package for 1-amino-alkylcylohexanes
WO2009071690A3 (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
WO2007022408A3 (en) Combination methods of saha and targretin for treating cancer
WO2007057221A3 (en) Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
WO2007144169A3 (en) Entacapone-derivatives
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2019194773A3 (en) The combination comprising linagliptin and metformin
WO2007145863A3 (en) Sustained release formulation of naltrexone
WO2006045314A3 (en) Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease
EP1902715A3 (en) Use of paliperidone for the treatment of psychiatric patients with reduced hepatic function
WO2020243273A3 (en) Methods of treating cholangiocarcinoma
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
WO2006079625A3 (en) Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20070203